课题基金 / 基金详情

Gene therapy for the treatment of chondrosarcoma

Gene therapy for the treatment of chondrosarcoma
软骨肉瘤的基因疗法
批准号:
12470306
负责人:
UCHIDA Atsumasa
金额:
$5.5万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2002

项目摘要

项目成果

UCHIDA Atsumasa的其他基金

相似基金

相关文献

中文摘要
翻译
利用细胞培养和独创的实验动物模型,在体外和体内研究了基因治疗软骨肉瘤的方法。细胞培养研究表明,加入抗病毒药物(更昔洛韦)后,合并自杀基因(单纯疱疹病毒胸苷激酶基因)的软骨肉瘤细胞具有细胞杀伤作用。以1:50的比例也证实了旁观者效应。软骨肉瘤细胞中的旁观者效应似乎是由间隙连接结构的存在引起的,这在电子显微镜下得到了证实。这些作用通过添加一些细胞杀伤细胞因子TRAIL和TNF α而增强。细胞凋亡导致细胞死亡。皮下注射自杀基因,再腹腔注射抗病毒药物,可明显抑制小鼠肿瘤的生长。自杀基因和抗病毒药物治疗4周后肿瘤大小为对照组的1 / 5。这些结果表明,通过自杀基因治疗软骨肉瘤是有效的治疗方法,除了手术没有有效的治疗方法。通过基因治疗提高软骨肉瘤的生存率,对其他恶性骨和软组织肉瘤的生存率有一定的促进作用。
英文摘要
Gene therapy for the treatment of chondrosarcoma was studied in vitro and in vivo using cell culture and an experimental animal model developed originally. Cell culture study showed cytocidal effect of chondrosarcoma cells incorporated suicide gene (thymidine kinase gene of herpes simplex virus) by addition of anti-virus agent (Ganciclovir). The bystander effect was also confirmed with the ratio of 1:50. The bystander effect in chondrosarcoma cells seems to be caused by the presence of the structure as gap junction which was demonstrated electron microscopically. These effects were enhanced by the addition of some cytocidal cytokines TRAIL and TNF α. Cell death was caused by apoptosis.Growth of the tumor implanted into the mice subcutaneously was markedly inhibited by injection of suicide gene into the tumor and thereafter intraabdominal administration of anti-virus agent. The tumor size after administration of suicide gene and anti-virus agent was one fifth of control after 4 weeks.These results suggest that gene therapy by suicide gene is useful for the treatment of chondrosarcoma which does not have effective treatments except surgery. Improvement of survival rate in chondrosarcoma by gene therapy will contribute to those in other malignant bone and soft tissue sarcomas.
期刊论文(64)
专著(0)
科研奖励(0)
会议论文
R Tomod, A Uchida, et al: "Telomerase Activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumor"Cancer. 95(5). 1127-1133 (2002)
R Tomod、A Uchida 等人:“端粒酶活性和人端粒酶逆转录酶 mRNA 表达与软组织肿瘤的临床侵袭性相关”癌症。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
M Seto: "Gene therapy of chondrosarcoma using retrovirus vectors encoding the herpes simplex virus thymidine kinase gene"Int J Oncology. 14. 1137-114 (1999)
M Seto:“使用编码单纯疱疹病毒胸苷激酶基因的逆转录病毒载体进行软骨肉瘤的基因治疗”Int J Oncology。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
M Hasegawa, Y Doi, A Uchida: "Cell-mediated bioresorption of sintered carbonate apatite in rabbits"J Bone Joint Surg. 85(B). 142-147 (2003)
M Hasekawa、Y Doi、A Uchida:“兔子体内烧结碳酸盐磷灰石的细胞介导生物吸收”J Bone Joint Surg。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
R Tomod, A Uchida, et al.: "Telomerase Activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumor"Cancer. 95(5). 1127-1133 (2002)
R Tomod、A Uchida 等人:“端粒酶活性和人端粒酶逆转录酶 mRNA 表达与软组织肿瘤的临床侵袭性相关”癌症。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
24
    Biology-based management in metastatic bone tumors
    • 批准号:
      18390412
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.13万
    • 财政年份:
      2006
    • 负责人:
      UCHIDA Atsumasa
    • 依托单位:
    Gene therapy for the treatment of bone and soft tissue tumors
    • 批准号:
      15390456
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.47万
    • 财政年份:
      2003
    • 负责人:
      UCHIDA Atsumasa
    • 依托单位:
    Study of pathogenesis and treatment in metastatic bone disease
    • 批准号:
      09470313
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $3.52万
    • 财政年份:
      1997
    • 负责人:
      UCHIDA Atsumasa
    • 依托单位:
    海外基金